Ikarian Capital, LLC Seelos Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $131,520 - $239,831	-257,883 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.84 - $1.71 $11,518 - $23,447	13,712 Added 5.62%	257,883 $215,000
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $60,280 - $103,083	-35,669 Reduced 12.75%	244,171 $589,000
Q2 2021 Aug 16, 2021	SELL	$2.64 - $6.32 $1.16 Million - $2.77 Million	-438,444 Reduced 61.04%	279,840 $739,000
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $969,683 - $3.58 Million	718,284 New	718,284 $3.59 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.